Vericel Q3 Revenue Rises 27% to $57.9 Million; Full-Year Profitability Guidance Raised
Vericel reported third-quarter 2024 total revenue of $57.9 million, up 27%, and a net loss of $0.9 million, or $0.02 per diluted share, compared with a $3.7 million loss a year earlier. The company raised its full-year profitability guidance to a 72% gross margin and 22% adjusted EBITDA margin, while keeping its full-year revenue guidance of $238 to $242 million, so shareholders see stronger margins but the company still reported a net loss.
Key points
- Q3 total revenue of $57.9 million, up from $45.6 million; MACI revenue $44.7 million and Burn Care revenue $13.2 million
- Q3 gross margin of 72%, up from 67%; operating expenses rose to $44.1 million from $35.7 million
- Q3 net loss of $0.9 million, or $0.02 per diluted share, versus $3.7 million, or $0.08 per share, in Q3 2023
- Full-year profitability guidance raised to 72% gross margin and 22% adjusted EBITDA margin, from 71% and 21%; revenue guidance maintained at $238 to $242 million
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:49 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 07, 2024.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.